Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prachi Bagadia

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Nature Immunology|June 10, 2015
Batf3 maintains autoactivation of Irf8 for commitment of a CD8α(+) conventional DC clonogenic progenitorGary E Grajales-Reyes, Arifumi Iwata, Jörn Albring, et al.
Cell Reports|March 29, 2018
Oral Antibiotic Treatment of Mice Exacerbates the Disease Severity of Multiple Flavivirus InfectionsLarissa B Thackray, Scott A Handley, Matthew J Gorman, et al.
Nature Immunology|August 14, 2019
An Nfil3-Zeb2-Id2 pathway imposes Irf8 enhancer switching during cDC1 developmentPrachi Bagadia, Xiao Huang, Tian-Tian Liu, et al.
Nature|August 14, 2020
cDC1 prime and are licensed by CD4<sup>+</sup> T cells to induce anti-tumour immunityStephen T Ferris, Vivek Durai, Renee Wu, et al.
Science (New York, N.Y.)|November 10, 2018
WDFY4 is required for cross-presentation in response to viral and tumor antigensDerek J Theisen, Jesse T Davidson, Carlos G Briseño, et al.
Immunity|May 18, 2021
Differential usage of transcriptional repressor Zeb2 enhancers distinguishes adult and embryonic hematopoiesisXiao Huang, Stephen T Ferris, Sunkyung Kim, et al.
Nature Immunology|August 14, 2019
Cryptic activation of an Irf8 enhancer governs cDC1 fate specificationVivek Durai, Prachi Bagadia, Jeffrey M Granja, et al.
Immunity|June 15, 2022
Indoleamine 2,3-dioxygenase 1 activation in mature cDC1 promotes tolerogenic education of inflammatory cDC2 via metabolic communicationMarco Gargaro, Giulia Scalisi, Giorgia Manni, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Nature Immunology|June 10, 2015
Batf3 maintains autoactivation of Irf8 for commitment of a CD8α(+) conventional DC clonogenic progenitorGary E Grajales-Reyes, Arifumi Iwata, Jörn Albring, et al.
Cell Reports|March 29, 2018
Oral Antibiotic Treatment of Mice Exacerbates the Disease Severity of Multiple Flavivirus InfectionsLarissa B Thackray, Scott A Handley, Matthew J Gorman, et al.
Nature Immunology|August 14, 2019
An Nfil3-Zeb2-Id2 pathway imposes Irf8 enhancer switching during cDC1 developmentPrachi Bagadia, Xiao Huang, Tian-Tian Liu, et al.
Nature|August 14, 2020
cDC1 prime and are licensed by CD4<sup>+</sup> T cells to induce anti-tumour immunityStephen T Ferris, Vivek Durai, Renee Wu, et al.
Science (New York, N.Y.)|November 10, 2018
WDFY4 is required for cross-presentation in response to viral and tumor antigensDerek J Theisen, Jesse T Davidson, Carlos G Briseño, et al.
Immunity|May 18, 2021
Differential usage of transcriptional repressor Zeb2 enhancers distinguishes adult and embryonic hematopoiesisXiao Huang, Stephen T Ferris, Sunkyung Kim, et al.
Nature Immunology|August 14, 2019
Cryptic activation of an Irf8 enhancer governs cDC1 fate specificationVivek Durai, Prachi Bagadia, Jeffrey M Granja, et al.
Immunity|June 15, 2022
Indoleamine 2,3-dioxygenase 1 activation in mature cDC1 promotes tolerogenic education of inflammatory cDC2 via metabolic communicationMarco Gargaro, Giulia Scalisi, Giorgia Manni, et al.
Pageof 2